SAT-330 COULD ADDING BORTEZOMIB HAVE BENEFIT FOR ANTIBODY...

Kidney International Reports 2020 / 03 Vol. 5; Iss. 3

SAT-330 COULD ADDING BORTEZOMIB HAVE BENEFIT FOR ANTIBODY MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION?

Dalili MD, N., Nafar, M., Panahandeh, M., Navid, P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
5
Journal:
Kidney International Reports
DOI:
10.1016/j.ekir.2020.02.350
Date:
March, 2020
File:
PDF, 337 KB
2020
Conversion to is in progress
Conversion to is failed